Figure 3
From: A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
Kaplan Meier overall survival: PLD treatment in all lines treatment.
Figure 3 | Journal of Ovarian Research
From: A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
Kaplan Meier overall survival: PLD treatment in all lines treatment.